Hillstar Bio

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$67M

Hillstar Bio is a biotechnology company developing immunology therapies that selectively target and deplete pathogenic immune cells to treat autoimmune diseases.